359 related articles for article (PubMed ID: 9700865)
1. [Rationale for prescribing oral contraceptives].
Teichmann AT
Wien Med Wochenschr; 1998; 148(7):171-4. PubMed ID: 9700865
[TBL] [Abstract][Full Text] [Related]
2. [Individualization of low-dose oral contraceptives. Pharmacological principles and practical indications for oral contraceptives].
Cianci A; De Leo V
Minerva Ginecol; 2007 Aug; 59(4):415-25. PubMed ID: 17923832
[TBL] [Abstract][Full Text] [Related]
3. [Influence of progestins on adverse effects of oral contraceptives].
Wynn V
Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):425-30. PubMed ID: 12280210
[TBL] [Abstract][Full Text] [Related]
4. [Effect of ethinyl estradiol-dienogest combination on serum androgen concentrations].
Oettel M; Carol W; Gräser T; Klinger G; Mellinger U; Moore C; Schindler AE; Winkler UH
Zentralbl Gynakol; 1997; 119(12):597-606. PubMed ID: 9483810
[TBL] [Abstract][Full Text] [Related]
5. [Current developments in hormonal contraception].
Kuhl H
Gynakologe; 1992 Aug; 25(4):231-40. PubMed ID: 1398252
[TBL] [Abstract][Full Text] [Related]
6. Effectivity and acceptability of oral contraceptives containing natural and artificial estrogens in combination with a gestagen. A controlled double-blind investigation.
Serup J; Bostofte E; Larsen S; Westergaard J
Acta Obstet Gynecol Scand; 1981; 60(2):203-6. PubMed ID: 7018165
[TBL] [Abstract][Full Text] [Related]
7. [Inhibition of ovulation with 35 micrograms of ethinyl estradiol and 2 mg of cyproterone acetate (Diane 35)].
Spona J; Huber J; Schmidt JB
Geburtshilfe Frauenheilkd; 1986 Jul; 46(7):435-8. PubMed ID: 3093307
[TBL] [Abstract][Full Text] [Related]
8. Three triphasic oral contraceptives now available in U.S.
Contracept Technol Update; 1985 Jan; 6(1):1-2, 4. PubMed ID: 12279912
[TBL] [Abstract][Full Text] [Related]
9. Effects on acne of two oral contraceptives containing desogestrel and cyproterone acetate.
Charoenvisal C; Thaipisuttikul Y; Pinjaroen S; Krisanapan O; Benjawang W; Koster A; Doesburg W
Int J Fertil Menopausal Stud; 1996; 41(4):423-9. PubMed ID: 8894800
[TBL] [Abstract][Full Text] [Related]
10. [Ovarian activity, cycle behavior and tolerance of low dosage oral contraceptives: a comparative study].
Rossmanith WG; Wirth U; Gasser S; Thun B; Steffens D
Zentralbl Gynakol; 1997; 119(11):538-44. PubMed ID: 9480608
[TBL] [Abstract][Full Text] [Related]
11. [Oral contraception with low-dose progestagen].
Heinzl S
Med Monatsschr Pharm; 1989 Apr; 12(4):123-4. PubMed ID: 2657358
[TBL] [Abstract][Full Text] [Related]
12. The choice of the dose of oestrogen in a combined oral contraceptive.
Smith M
Fertil Contracept; 1978 Apr; 2(2):22-3. PubMed ID: 12336093
[TBL] [Abstract][Full Text] [Related]
13. [A comparative clinical study of the effects of three types of low-dose estrogen/progestogen oral contraceptives].
Chen JK
Shengzhi Yu Biyun; 1987 May; 7(2):11-6. PubMed ID: 12268918
[TBL] [Abstract][Full Text] [Related]
14. [A new ovulation inhibitor antiandrogen].
Millet-part A; Blanes-espi A; Ferrer-barriendos J; Siqueira L; Acosta E
J Bras Ginecol; 1984 Mar; 94(3):91-7. PubMed ID: 12266391
[TBL] [Abstract][Full Text] [Related]
15. Yasmin: the reason why.
Thorneycroft IH
Eur J Contracept Reprod Health Care; 2002 Dec; 7 Suppl 3():13-8; discussion 42-3. PubMed ID: 12659402
[TBL] [Abstract][Full Text] [Related]
16. [Ovarian suppression with Diane 35/50].
Erdmann D; Schindler EM; Schindler AE
Geburtshilfe Frauenheilkd; 1994 Nov; 54(11):627-33. PubMed ID: 8719015
[TBL] [Abstract][Full Text] [Related]
17. [Metrorrhagia caused by estrogen-progestin combinations].
Erny R; Erny N
Contracept Fertil Sex (Paris); 1994 Feb; 22(2):93-7. PubMed ID: 12319056
[TBL] [Abstract][Full Text] [Related]
18. [Hormonal contraception--side effects and surgical aspects (author's transl)].
Göretzlehner G; Carol W; Köhler G
Zentralbl Chir; 1980; 105(24):1601-16. PubMed ID: 7015744
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the impact of vaginal and oral administration of combined hormonal contraceptives on hepatic proteins sensitive to estrogen.
Sitruk-Ware RL; Menard J; Rad M; Burggraaf J; de Kam ML; Tokay BA; Sivin I; Kluft C
Contraception; 2007 Jun; 75(6):430-7. PubMed ID: 17519148
[TBL] [Abstract][Full Text] [Related]
20. A pharmacokinetic study with a low-dose oral contraceptive containing 20 microg ethinylestradiol plus 100 microg levonorgestrel.
Endrikat J; Blode H; Gerlinger C; Rosenbaum P; Kuhnz W
Eur J Contracept Reprod Health Care; 2002 Jun; 7(2):79-90. PubMed ID: 12201326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
